Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06780176 · ClinicalTrials.gov registry record
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
A clinical trial of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 3
- Study locations
NCT06780176 is a study of Breast Cancer and Breast Neoplasms that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 800 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06780176, a study of Breast Cancer and Breast Neoplasms, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
Conditions Studied
Interventions
- OTHER Biospecimen Collection
- DIAGNOSTIC_TEST Surgical Tissue Collection
- BEHAVIORAL Survey Collection
Study Locations (3)
California
- University of California, Los Angeles (Specimen Analysis only) - Los Angeles
Florida
- University of Miami (Data Collection Only) - Miami
New York
- Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2030-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06780176
The ClinicalTrials.gov registry entry for NCT06780176 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT06780176 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06780176 about?
NCT06780176 is a clinical study titled "A Study of Breast Cancer Risk Factors and Outcomes of People in Florida". The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
What is the current status of trial NCT06780176?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2025-01-13. Estimated completion is 2030-01-13.
What conditions does trial NCT06780176 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Breast Diseases.
What interventions are being tested in trial NCT06780176?
The interventions under investigation include: Biospecimen Collection (OTHER), Surgical Tissue Collection (DIAGNOSTIC_TEST), Survey Collection (BEHAVIORAL).
Who is sponsoring clinical trial NCT06780176?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06780176 being conducted?
This trial has 3 study locations across California, Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.